Core Viewpoint - The acquisition of Pengli Bio by Aopumai through a "share issuance + cash" method has been approved, marking the first A-share transaction to implement both "installment payment for restructuring shares" and "lock-up period linked to private equity funds" since the introduction of the "six merger rules" [2][3] Group 1 - The transaction breaks the traditional "one-time payment" model, with Aopumai initially paying only 69.13% of the shares, while the remaining portion is linked to performance targets and will be paid in three installments [2] - The "installment payment" approach mitigates risks associated with high premium valuations and performance commitments, aligning the interests of the acquired company's core team with the long-term development of the listed company [2][3] - The "lock-up period linked to private equity funds" allows four private equity firms to reduce their lock-up period from 12 months to 6 months, enhancing the flexibility of risk capital exit and encouraging more active participation in industrial mergers [3] Group 2 - Aopumai's acquisition employs a differentiated pricing mechanism, where the price per share varies based on shareholder type and investment cost, with valuations of 1.23 billion yuan for the controlling shareholder, 1.32 billion yuan for the management team, and 1.55 billion yuan for financial investors [3][4] - The differentiated pricing accommodates the varying demands of different capital backgrounds, addressing the challenges of achieving consensus among multiple shareholders in merger negotiations [4] - The case of Aopumai serves as a reference for improving merger success rates by utilizing "installment payments + differentiated pricing + lock-up period linkage," shifting the focus from transaction-oriented to governance-oriented approaches [5]

Core Viewpoint - The announcement details the change of the continuous supervision sponsor representative for Anhui Jinchun Nonwoven Fabric Co., Ltd. from Chen Lei to Wang Jianwei due to work changes, while ensuring that the supervision responsibilities continue without interruption [1][2]. Group 1: Change of Sponsor Representative - The original sponsor representative, Chen Lei, is replaced by Wang Jianwei from CITIC Jianan Securities for the ongoing supervision of the company's IPO project [1]. - The continuous supervision period is from August 24, 2020, to December 31, 2023, and the company has not yet fully utilized the raised funds from the IPO [1]. Group 2: Company’s Response to Shareholder Suggestions - The company received a shareholder suggestion letter regarding the acquisition of 51% of Anhui Jinsengyuan Material Technology Co., Ltd. for 51.918 million yuan [5][6]. - The target company reported revenues of 71.11 million yuan in 2024 and 23.17 million yuan from January to August 2025, with a projected decline in revenue for 2025 [6]. - The company has set performance commitments for the target company to ensure the protection of shareholder interests, with net profit commitments of 700,000 yuan, 1.2 million yuan, and 1.3 million yuan for 2025 to 2027 [6][12]. Group 3: Transaction Details and Valuation - The acquisition price for the 51% stake in the target company is set at 51.918 million yuan, with a valuation increase of 71.65 million yuan, representing a 237.66% increase [6][9]. - The static price-to-earnings ratio for the transaction is 12.01, which is lower than the industry average of 15.04, indicating a reasonable valuation [10]. Group 4: Performance Commitment and Payment Terms - The transaction includes performance commitments and a structured payment plan based on the achievement of these commitments, with payments scheduled at 60%, 30%, and 10% over the commitment period [13][14]. - The performance commitments are designed to align the interests of the company and its shareholders, ensuring that the target company meets its financial goals [12][17]. Group 5: Company’s Financial Health - The company has a strong cash position, with 384.9 million yuan in cash as of September 30, 2025, ensuring that the acquisition will not adversely affect its financial status [18]. - The structured payment terms are intended to mitigate financial pressure while ensuring compliance with performance commitments [18].